#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	Q4R	NONSYN	10	12	CAG	134	136	CGG	12;12;14	C;G;G	12;12;14	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	S18T	NONSYN	52	54	TCC	176	178	ACC	20;20;19	A;C;C	20;20;19	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	S30A	NONSYN	88	90	TCG	212	214	GCG	21;21;22	G;C;G	21;21;22	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	N78E	NONSYN	232	234	AAT	356	358	GAA	17;17;17	G;A;A	14;16;12	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	P84L	NONSYN	250	252	CCG	374	376	CTG	17;17;17	C;T;G	17;17;17	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	N146V	NONSYN	436	438	AAC	560	562	GTC	14;14;15	G;T;C	13;14;15	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	P191L	NONSYN	571	573	CCT	695	697	CTT	25;25;25	C;T;T	24;24;24	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	Q220P	NONSYN	658	660	CAG	782	784	CCG	21;21;23	C;C;G	21;21;23	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	A274P	NONSYN	820	822	GCG	944	946	CCG	14;15;15	C;C;G	14;15;14	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	266	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1141	17.4	0	.	p	.	0	I278V	NONSYN	832	834	ATC	956	958	GTC	14;13;13	G;T;C	14;13;13	.	AAC(3)-IIa;AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	248	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1248	15.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	394	396	ACG	20;20;20	A;C;G	20;20;20	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CTX_M_15.3001878.AY044436.1435_2311.1430	CTX_M_15.3001878.AY044436.1435_2311.1430	1	0	27	304	CTX_M_1+	876	876	100.0	CTX_M_1+.l6.c4.ctg.1	1585	14.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CTX-M-15 is a beta-lactamase found in the Enterobacteriaceae family;CTX-M-15
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1425	1427	AGC	15;15;15	A,G;G;C	6,9;15;15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	1	SNP	p	R234F	1	.	.	700	702	TTC	900	902	TTC	61;60;60	T;T;C	61;60;60	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1200	1202	CGT	51;51;52	C;G;T	51;51;52	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	0	HET	.	.	.	C255T	.	255	255	C	455	455	C	52	C,T	29,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	0	HET	.	.	.	C996A	.	996	996	C	1196	1196	C	47	C,A	32,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	868	Escherichia_coli_EF_Tu	1230	1230	99.51	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1653	38.3	0	HET	.	.	.	T999C	.	999	999	T	1199	1199	T	49	T,C	34,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	406	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1762	17.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1476	1478	AAA	12;10;10	A;A;A	12;10;10	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	490	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1857	19.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1297	1299	GAA	28;27;27	G;A;A	27;27;26	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	90	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	707	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	84	G	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	89	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	102	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	110	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	103	C,T	101,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	83	A	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	80	A	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	78	A	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	72	T	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	71	C	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	67	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	66	A	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	68	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	69	C	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	69	T	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	83	G	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	85	G	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	85	T	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	129	T	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	124	G	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	113	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	109	A	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	72	C	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	67	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	59	G	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	54	C	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	61	T	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	61	G	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	60	T,C	59,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	544	84.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	111	C	111	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	C990G	SNP	990	990	C	62	62	G	31	G	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	T1002A	SNP	1002	1002	T	74	74	A	24	A	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	A1004G	SNP	1004	1004	A	76	76	G	24	G	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	C1011T	SNP	1011	1011	C	83	83	T	22	T	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	C1023A	SNP	1023	1023	C	95	95	A	23	A	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	T1024A	SNP	1024	1024	T	96	96	A	22	A	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	T1041G	SNP	1041	1041	T	113	113	G	31	G	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	187	93.05	Pasteurella_multocida_16S.l15.c17.ctg.3	187	34.7	0	.	n	.	0	A1042T	SNP	1042	1042	A	114	114	T	31	T	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	C990G	SNP	990	990	C	61	61	G	20	G	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	T1002A	SNP	1002	1002	T	73	73	A	18	A	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	A1003C	SNP	1003	1003	A	74	74	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	G1008C	SNP	1008	1008	G	79	79	C	17	C	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	C1011T	SNP	1011	1011	C	82	82	T	17	T	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	T1012C	SNP	1012	1012	T	83	83	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	C1023A	SNP	1023	1023	C	93	93	A	18	A	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	.1025G	INS	1025	1025	T	96	96	G	22	G	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	T1041G	SNP	1041	1041	T	112	112	G	30	G	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1222	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c17.ctg.4	186	21.6	0	.	n	.	0	A1042T	SNP	1042	1042	A	113	113	T	28	T	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	390	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1456	20.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	208	210	CGT	14;15;15	C;G;T	14;15;15	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	390	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1456	20.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	292	294	ATC	28;27;27	A,G;T;C	27,1;27;27	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	390	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1456	20.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1051	1053	GGC	19;19;19	G;G;C	19;19;19	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	566	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2145	19.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	290	292	AGC	10;10;10	A;G;C	10;10;10	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	566	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2145	19.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	692	694	CTA	21;21;21	C;T;A	21;21;21	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	566	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2145	19.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1211	1213	CAA	28;27;27	C;A;A	28;27;27	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	566	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2145	19.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1310	1312	GGT	34;34;34	G;G;T	33;33;33	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	566	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2145	19.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1880	1882	GTT	13;12;13	G;T;T	13;12;13	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	210	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1468	10.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	544	546	GAA	6;7;7	G;A;A	5;6;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	210	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1468	10.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	724	726	ACC	10;10;11	A;C;C	10;10;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	210	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1468	10.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	844	846	ACT	12;12;12	A;C;T	12;12;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	210	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1468	10.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1234	1236	ATC	10;10;10	A;T;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	324	PmrF	969	969	99.38	PmrF.l6.c4.ctg.1	1513	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aadA24.3002621.DQ677333.0_780.330	aadA24.3002621.DQ677333.0_780.330	1	0	513	318	aad-	780	639	99.22	aad-.l15.c4.ctg.1	1197	14.0	0	.	p	.	0	E232del	DEL	694	694	G	882	882	G	14	G	14	.	aadA24 is an integron-encoded aminoglycoside nucleotidyltransferase gene in Salmonella spp.;aadA24
aadA24.3002621.DQ677333.0_780.330	aadA24.3002621.DQ677333.0_780.330	1	0	513	318	aad-	780	123	95.93	aad-.l15.c4.ctg.2	628	11.1	0	.	p	.	0	L13V	NONSYN	37	39	CTA	267	269	GTT	31;31;32	G;T;T	31;31;32	.	aadA24 is an integron-encoded aminoglycoside nucleotidyltransferase gene in Salmonella spp.;aadA24
aadA24.3002621.DQ677333.0_780.330	aadA24.3002621.DQ677333.0_780.330	1	0	513	318	aad-	780	123	95.93	aad-.l15.c4.ctg.2	628	11.1	0	.	p	.	0	S14G	NONSYN	40	42	AGC	270	272	GGC	32;29;29	G;G;C	32;29;29	.	aadA24 is an integron-encoded aminoglycoside nucleotidyltransferase gene in Salmonella spp.;aadA24
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	996	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3517	21.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	500	502	ATC	25;25;25	A;T;C	25;25;25	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	996	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3517	21.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2213	2215	AAG	16;17;17	A;A;G	16;17;17	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	442	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1645	20.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	253	255	GTC	11;11;12	G;T;C,T	11;11;11,1	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	442	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1645	20.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	994	996	TGC	39;38;39	T;G;C	39;38;39	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	822	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3105	19.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	385	385	T	14	T	14	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	822	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3105	19.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	691	693	GAC	18;18;17	G;A;C	18;18;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	822	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3105	19.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	967	969	TTA	17;17;17	T;T;A	17;17;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	822	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3105	19.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1150	1152	AAT	17;16;17	A;A;T	17;16;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	822	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3105	19.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1937	1937	T	32	T	32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	184	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1189	11.4	1	SNP	p	R45C	0	.	.	133	135	CGC	449	451	CGC	19;20;22	C;G;C	19;20;22	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	122	acrS	663	663	98.64	acrS.l15.c30.ctg.1	926	9.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	199	201	TTC	7;8;8	T;T;C	7;8;8	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	122	acrS	663	663	98.64	acrS.l15.c30.ctg.1	926	9.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	463	465	GGG	13;12;12	G;G;G	13;12;12	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	178	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1151	11.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	573	575	CTT	19;19;19	C;T;T	19;19;19	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	908	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3045	22.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2091	2093	GCA	35;34;34	G;C;A	35;34;34	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	908	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3045	22.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2352	2354	ACC	30;29;29	A;C;C	29;29;29	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	908	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3045	22.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2661	2663	GCC	21;24;23	G;C;C	21;24;23	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	438	440	GCT	5;6;7	G;C;T	5;6;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	558	560	GAG	11;10;10	G;A;G	11;10;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	594	596	TGC	8;8;8	T;G;C	8;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	777	779	GTT	16;16;16	G;T;T	16;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	927	929	CAC	17;16;16	C;A;C	17;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1212	1214	ATG	23;23;23	A;T;G	23;23;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	514	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2560	15.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2208	2210	CGC	14;14;14	C;G;C	14;14;14	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	206	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1143	13.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	851	853	ACC	9;9;9	A;C;C	9;9;9	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	206	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1143	13.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	863	865	TCG	10;10;11	T;C;G	10;10;11	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	194	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1314	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	310	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1818	12.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1349	1351	AAA	9;9;9	A;A;A	9;9;9	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	310	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1818	12.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1361	1363	GAG	10;10;10	G;A;G	10;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	310	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1818	12.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1367	1369	CAC	10;10;10	C;A;C	10;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	310	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1818	12.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1421	1423	GAG	10;10;10	G;A;G	10;10;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	27	244	TEM_1+	861	861	100.0	TEM_1+.l15.c4.ctg.1	1197	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	422	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1947	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	254	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1127	17.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	244	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1304	14.0	0	.	p	.	0	A146T	NONSYN	436	438	GCT	563	565	ACT	16;17;17	A;C;T	16;17;17	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	124	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	730	12.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	308	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1565	14.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1009	1011	GTC	22;22;20	G;T;C	22;22;20	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	574	emrB	1539	1539	99.74	emrB.l15.c17.ctg.1	2009	21.4	0	.	p	.	0	E197K	NONSYN	589	591	GAA	842	844	AAA	23;23;23	A,G;A;A	22,1;22;23	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	340	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1582	15.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	794	796	AGC	21;20;20	A;G;C	21;20;20	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	18	emrE_1	333	215	94.88	emrE_1.l6.c30.ctg.1	297	3.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	228	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1459	11.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	740	742	AGG	8;7;7	A;G;G	8;7;7	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	228	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1459	11.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1130	1132	GAC	11;11;12	G;A;C	11;11;12	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	166	emrR	531	531	100.0	emrR.l15.c30.ctg.1	972	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	334	emrY	1539	1539	99.81	emrY.l6.c4.ctg.1	1996	12.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	112	evgA	615	615	99.19	evgA.l15.c30.ctg.1	947	8.9	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	356	358	CTG	8;8;9	C;T;G	8;8;9	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	264	266	ATA	11;10;10	A;T;A	11;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	276	278	GTA	12;12;12	G;T;A	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	429	431	ACG	10;11;10	A;C;G	10;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	492	494	GAA	13;13;13	G;A;A	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	531	533	GCT	11;10;10	G;C;T	11;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	549	551	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	636	638	TCA	13;14;15	T;C;A	13;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	765	767	CAG	11;12;12	C;A;G	11;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	903	905	GTT	7;7;7	G;T;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1059	1061	GAT	8;8;8	G;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1227	1229	AAT	13;13;13	A;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1248	1250	TTA	12;12;12	T;T;A	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1449	1451	AAA	5;5;5	A;A;A	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2184	2186	CAT	11;11;11	C;A;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2238	2240	CAT	8;8;8	C;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2256	2258	AGA	9;9;10	A;G;A	9;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2271	2273	AAT	10;10;10	A;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2418	2420	TCC	15;14;14	T;C;C	15;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2583	2585	ATT	21;21;21	A;T;T	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2604	2606	GAT	17;17;15	G;A;T	17;17;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2718	2720	GTT	23;23;23	G;T;T	23;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	696	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4017	13.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3003	3005	CAC	16;16;16	C;A;C	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	252	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1328	14.0	1	SNP	p	P64L	0	.	.	190	192	CCA	390	392	CCA	22;23;22	C;C;A	22;23;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	252	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1328	14.0	1	SNP	p	P64A	0	.	.	190	192	CCA	390	392	CCA	22;23;22	C;C;A	22;23;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	252	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1328	14.0	1	SNP	p	P64H	0	.	.	190	192	CCA	390	392	CCA	22;23;22	C;C;A	22;23;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	252	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1328	14.0	1	SNP	p	P64R	0	.	.	190	192	CCA	390	392	CCA	22;23;22	C;C;A	22;23;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	252	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1328	14.0	1	SNP	p	P64S	0	.	.	190	192	CCA	390	392	CCA	22;23;22	C;C;A	22;23;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	122	gadE	528	528	100.0	gadE.l15.c4.ctg.1	913	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	85	87	ATG	3;3;3	A;T;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	88	90	CCG	3;3;3	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	121	123	GAA	5;5;5	G;A;A	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	124	126	TCC	5;5;5	T;C;C	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	127	129	GGG	5;4;4	G;G;G	5;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	151	153	AAT	2;2;2	A;A;T	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	54	gadW	729	552	94.2	gadW.l15.c4.ctg.1	633	6.4	0	.	p	.	0	S234A	NONSYN	700	702	TCG	523	525	GCG	5;5;5	G;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	166	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	12.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	300	302	TTA	13;12;12	T;T;A	13;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	166	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	12.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	378	380	ATT	14;14;14	A;T;T	14;14;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	166	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	12.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	879	881	GGA	12;11;10	G;G;A	12;11;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	166	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	12.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	885	887	CCG	7;7;6	C;C;G	7;7;6	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2157	2159	GAA	22;22;22	G;A;A	22;22;22	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	S83W	0	.	.	247	249	TCG	372	374	TCG	22;22;22	T;C;G	22;22;22	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	S83I	0	.	.	247	249	TCG	372	374	TCG	22;22;22	T;C;G	22;22;22	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	S83L	0	.	.	247	249	TCG	372	374	TCG	22;22;22	T;C;G	22;22;22	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	D87H	0	.	.	259	261	GAC	384	386	GAC	24;24;25	G;A;C	24;23;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	D87N	0	.	.	259	261	GAC	384	386	GAC	24;24;25	G;A;C	24;23;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	D87V	0	.	.	259	261	GAC	384	386	GAC	24;24;25	G;A;C	24;23;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	384	386	GAC	24;24;25	G;A;C	24;23;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	926	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2980	23.3	1	SNP	p	D87G	0	.	.	259	261	GAC	384	386	GAC	24;24;25	G;A;C	24;23;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136L	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136S	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136H	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136E	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136I	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136G	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	694	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2871	18.2	1	SNP	p	R136C	0	.	.	406	408	CGC	604	606	CGC	20;18;19	C;G;C	20;18;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	154	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	932	12.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	440	442	CCG	11;11;12	C;C;G	11;11;12	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	154	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	932	12.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	593	595	GCC	15;14;14	G;C;C	14;14;14	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	296	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1294	16.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	195	197	TCA	14;15;15	T;C;A	14;15;15	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	116	marA	384	384	99.74	marA.l15.c4.ctg.1	897	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	500	502	AGC	6;6;6	A;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	602	604	CAT	6;6;6	C;A;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	V45E	0	.	.	133	135	GTG	326	328	GTG	10;10;10	G;T;G	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	I49S	0	.	.	145	147	ATC	338	340	ATC	11;11;11	A;T;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	A70T	0	.	.	208	210	GCA	401	403	GCA	9;9;9	G;C;A	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R73C	0	.	.	217	219	CGT	410	412	CGT	9;9;8	C;G;T	9;9;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R73S	0	.	.	217	219	CGT	410	412	CGT	9;9;8	C;G;T	9;9;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R77L	0	.	.	229	231	CGC	422	424	CGC	7;6;7	C;G;C	7;6;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R77C	0	.	.	229	231	CGC	422	424	CGC	7;6;7	C;G;C	7;6;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	L78M	0	.	.	232	234	CTG	425	427	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R94S	0	.	.	280	282	CGC	473	475	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	R94H	0	.	.	280	282	CGC	473	475	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	64	marR	435	435	97.7	marR.l15.c4.ctg.1	792	6.0	1	SNP	p	V96E	0	.	.	286	288	GTA	479	481	GTA	8;8;8	G;T;A	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	64	66	TTC	5;5;5	T;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	151	153	ATC	6;6;6	A;T;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	169	171	GCC	7;7;8	G;C;C	7;7;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	172	174	GTG	8;8;8	G;T;G	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	199	201	GAT	10;9;9	G;A;T	10;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	220	222	ACC	14;14;14	A;C;C	14;14;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	247	249	TTA	12;12;12	T;T;A	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	388	390	CAG	23;22;22	C;A;G	23;22;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	427	429	GCC	26;26;26	G;C;C	25;25;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	532	534	GCG	18;18;20	G;C;G	18;18;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	736	738	GTT	17;17;17	G;T;T	16;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	274	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1443	13.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	898	898	C	18	C	18	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	V12trunc	TRUNC	34	34	G	275	275	G	12	G	12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	332	334	CAG	11;10;9	C;A;G	11;10;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	T83I	NONSYN	247	249	ACC	482	484	ATC	7;7;6	A;T;C	7;7;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	I99M	NONSYN	295	297	ATA	530	532	ATG	11;11;11	A;T;G	11;11;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	A130T	NONSYN	388	390	GCC	623	625	ACC	18;18;19	A;C;C	18;17;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	346	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1737	14.9	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1004	1006	ACG	23;23;24	A,C;C;G	22,1;23;24	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1889	1891	ACC	25;25;25	A;C;C	25;25;25	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2282	2284	CAA	22;22;22	C;A;A	22;22;22	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2450	2452	ATT	15;15;16	A;T;T	15;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2534	2536	GTT	23;23;23	G;T;T	23;23;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2642	2644	GAG	27;27;28	G;A;G	27;27;27	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2870	2872	ATG	14;15;16	A;T;G	14;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1054	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3407	22.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3005	3007	GAT	26;25;25	G;A;T	25;25;25	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3201	21.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	194	196	ATG	17;17;17	A;T;G	14;16;14	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3201	21.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	680	682	ATC	25;25;25	A;T;C	25;25;25	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3201	21.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2996	2998	CAC	9;9;9	C;A;C	9;8;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3201	21.5	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	2999	3001	CTC	9;10;11	C;T;C	9;10;11	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	482	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1836	19.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	192	194	GAA	10;10;10	G;A;A	10;10;10	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	482	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1836	19.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	861	863	GCG	17;18;17	G;C;G	17;18;17	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	482	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1836	19.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1203	1205	ATC	26;28;28	A;T;C	26;28;28	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	482	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1836	19.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1506	1508	TTT	26;26;27	T;T;T	26;26;27	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	460	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1634	20.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	996	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3661	20.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1132	1134	ACC	10;10;10	A;C;C	10;10;10	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	996	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3661	20.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2374	2376	GAC	23;24;24	G;A;C	23;24;24	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	360	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1482	16.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	606	608	ATC	13;13;13	A;T;C	13;13;13	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	360	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	422	6.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	163	165	GGA	5;5;5	G;G;A	5;5;5	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	402	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1561	19.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	572	574	TGT	22;22;23	T;G;T	22;22;23	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	402	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1561	19.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1142	1144	TTG	16;17;17	T;T;G	16;17;17	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	402	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1561	19.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1352	1354	ACG	6;6;6	A;C;G	6;6;6	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	400	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1734	17.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	856	858	TCC	16;16;17	T;C;C	15;16;17	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	324	mdtN	1032	1032	98.06	mdtN.l6.c4.ctg.1	1402	17.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	524	526	ATT	16;16;16	A;T;T	16;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	197	199	ATG	8;8;9	A;T;G	8;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	263	265	ATC	13;13;13	A;T;C	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	512	514	CGC	23;24;26	C;G;C	23;24;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	878	880	AGC	20;21;21	A;G;C	20;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1079	1081	GTG	24;24;24	G;T;G	23;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1142	1144	AAC	14;14;14	A;A,C;C	12;10,1;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1187	1189	GTC	16;15;16	G;T;C	16;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1217	1219	ATA	17;18;18	A;T;A	17;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1325	1327	TCT	29;29;28	T;C;T	29;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1712	1714	GCG	19;17;17	G;C;G	19;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	656	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2511	19.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1925	1927	ATC	11;11;11	A;T;C	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	583	585	GCG	21;21;20	G;C;G	20;21;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	757	759	ACC	20;20;21	A;C;C	20;20;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	829	831	CGC	15;15;15	C;G;C	15;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	946	948	GCT	17;17;17	G;C;T	17;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1030	1032	AAA	11;11;11	A;A;A	11;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1048	1050	CGA	12;11;12	C;G;A	12;11;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1213	1215	GCC	15;15;15	G;C;C	15;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1225	1227	GAT	10;11;11	G;A;T	10;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	370	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1827	15.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1642	1644	GCT	6;6;6	G;C;T	6;6;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1016	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3760	20.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1477	1479	AAG	14;14;14	A;A;G	14;14;14	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1016	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3760	20.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2554	2556	CTG	18;18;18	C;T;G	18;18;18	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	74	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	612	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	610	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2238	20.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1041	1043	AAC	22;23;23	A;A;C	22;23;23	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	610	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2238	20.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1587	1589	ATA	29;29;29	A;T;A	28;29;29	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	430	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1655	19.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1336	1338	GAT	31;31;31	G;A;T	31;31;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	430	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1655	19.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1339	1341	CTG	31;30;29	C;T;G	31;30;29	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	248	250	TGT	18;18;17	T;G;T	18;18;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	0	.	p	.	0	I117T	NONSYN	349	351	ATC	518	520	ACC	17;18;18	A;C;C	17;17;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	0	.	p	.	0	G187D	NONSYN	559	561	GGC	728	730	GAC	13;13;13	G;A;C	13;13;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	1	SNP	p	R15C	0	.	.	43	45	CGC	212	214	CGC	17;15;15	C;G;C	17;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	1	SNP	p	S33R	0	.	.	97	99	AGC	266	268	AGC	21;22;22	A;G;C	21;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	1	SNP	p	G131D	0	.	.	391	393	GGC	560	562	GGC	12;12;12	G;G;C	12;11;11	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	1	SNP	p	R203C	0	.	.	607	609	CGT	776	778	CGT	13;13;13	C;G;T	13;13;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	190	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1081	12.9	1	SNP	p	R203L	0	.	.	607	609	CGT	776	778	CGT	13;13;13	C;G;T	13;13;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	362	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1554	17.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1086	1088	GAG	18;18;18	G;A;G	18;18;18	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	362	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1554	17.3	1	SNP	p	G141D	0	.	.	421	423	GGT	573	575	GGT	39;39;39	G;G;T	39;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	362	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1554	17.3	1	SNP	p	G141E	0	.	.	421	423	GGT	573	575	GGT	39;39;39	G;G;T	39;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	362	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1554	17.3	1	SNP	p	R154A	0	.	.	460	462	CGT	612	614	CGT	30;31;31	C;G;T	30;31;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	362	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1554	17.3	1	SNP	p	R154D	0	.	.	460	462	CGT	612	614	CGT	30;31;31	C;G;T	30;31;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1920	1922	GTG	22;21;20	G;T,C;G	22;20,1;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1947	1949	TCG	22;23;23	T;C;G	22;22;23	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2562	2564	AAC	13;13;13	A;A;C	13;12;12	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	1	SNP	p	A85T	0	.	.	253	255	GCG	576	578	GCG	26;27;27	G;C;G	26;27;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	1	SNP	p	D111H	0	.	.	331	333	GAT	654	656	GAT	21;21;21	G;A;T	21;21;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	806	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2723	22.1	1	SNP	p	S129P	0	.	.	385	387	TCC	708	710	TCC	24;24;23	T;C;C	24;24;23	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	576	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2327	18.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1649	1651	AAC	23;25;24	A;A;C	23;25;24	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	576	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2327	18.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1658	1660	GAT	28;29;29	G;A;T	28;29;29	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	502	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1845	20.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	748	750	CAG	30;30;30	C;A;G	30;30;30	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	502	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1845	20.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1222	1224	GAT	19;20;19	G;A;T	19;20;19	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	V146F	0	.	.	436	438	GTT	743	745	GTT	16;16;16	G;T;T	16;16;16	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1844	1846	CAG	24;24;25	C;A;G	24;24;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1844	1846	CAG	24;24;25	C;A;G	24;24;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1883	1885	CAC	27;27;26	C;A;C	27;27;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1892	1894	CGT	25;25;25	C;G;T	25;25;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1892	1894	CGT	25;25;25	C;G;T	25;25;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1898	1900	TCC	24;25;24	T;C;C	24;25;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1904	1906	CTC	20;20;22	C;T;C	20;20;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1994	1996	ACC	20;20;20	A;C;C	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1997	1999	CCT	20;20;19	C;C;T	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1322	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4514	22.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2366	2368	CGT	38;38;38	C;G;T	37;38;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	.	n	.	0	A226G	SNP	226	226	A	253	253	G	186	G	183	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	1	SNP	n	A794T	0	.	.	794	794	A	821	821	A	193	A	191	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	1	SNP	n	A794G	0	.	.	794	794	A	821	821	A	193	A	191	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	1	SNP	n	G926C	0	.	.	926	926	G	953	953	G	138	G	138	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	1	SNP	n	G926A	0	.	.	926	926	G	953	953	G	138	G	138	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	1	SNP	n	G926T	0	.	.	926	926	G	953	953	G	138	G	138	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	A79G	.	79	79	A	106	106	A	171	A,G	126,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	C719T,A	.	719	719	C	746	746	C	195	C,T,A	98,95,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	T273A	.	273	273	T	300	300	T	185	T,A	142,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	C183T	.	183	183	C	210	210	C	177	C,T	120,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	A250T	.	250	250	A	277	277	A	171	A,T	131,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	T90C	.	90	90	T	117	117	T	165	T,C	123,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	G474A	.	474	474	G	501	501	G	175	G,A	127,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	A253T	.	253	253	A	280	280	A	173	A,T	132,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	G895A	.	895	895	G	922	922	G	152	G,A	133,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1028	172.8	0	HET	.	.	.	C194T	.	194	194	C	221	221	C	173	C,T	137,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	793	123.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	171	A	170	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	793	123.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	171	A	170	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	793	123.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	171	A	170	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	G1002A	SNP	1002	1002	G	76	76	A	51	A,G	50,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	G1006C	SNP	1006	1006	G	80	80	C	50	C	50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	T1010C	SNP	1010	1010	T	84	84	C	50	C	50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	A1019.	DEL	1019	1019	A	92	92	G	45	G	45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	.1023G	INS	1023	1023	T	97	97	G	47	G	47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	187	96.28	rrsB+.l15.c30.ctg.3	187	52.6	0	.	n	.	0	C1038T	SNP	1038	1038	C	112	112	T	52	T	52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4130	rrsB+	1542	179	100.0	rrsB+.l15.c30.ctg.4	179	40.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	196	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	898	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	204	soxR	465	465	100.0	soxR.l15.c30.ctg.1	955	16.0	1	SNP	p	R20H	0	.	.	58	60	CGC	390	392	CGC	29;29;30	C;G;C	29;29;29	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	204	soxR	465	465	100.0	soxR.l15.c30.ctg.1	955	16.0	1	SNP	p	G121D	0	.	.	361	363	GGT	693	695	GGT	22;22;22	G;G;T,G	22;22;21,1	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	142	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	924	11.6	1	SNP	p	A12S	0	.	.	34	36	GCA	377	379	GCA	23;24;25	G;C;A	23;24;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	672	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c17.ctg.1	1259	40.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	704	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c30.ctg.1	1401	37.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	482	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1313	27.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	734	tetA	1200	1200	100.0	tetA.l15.c30.ctg.1	1714	31.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	490	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1165	31.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	492	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1982	18.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
